PATH Stock Slips As UBS Trims Price Target To $12

UiPath Inc. stocks have been trading down by -4.67 percent amid negative sentiment over slowing automation demand and competitive pressures.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading PATH

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

UBS cut its UiPath price target from $13 to $12 while keeping a Neutral rating on PATH.
The move signals slightly lower expectations for PATH, not a total reset of the long‑term story.
Shares of PATH recently faded toward the low $10s after trading near $12 earlier this month.
PATH’s fundamentals show strong margins and solid cash, but growth is slowing versus prior years.

Quick Financial Overview

UiPath Inc. (PATH) is trading like a stock stuck between stories. On the one hand, PATH just printed quarterly revenue of about $418.4M, with a gross margin near 83%. That’s elite software territory. The company turned that into roughly $28M in operating income and about $22.5M in net income, or $0.04 per diluted share. So PATH is no longer a pure cash burner.

Free cash flow for the quarter was about $129.2M, which is real firepower. PATH also ended the period with more than $632M in cash and about $1.31B when you include short‑term investments, against modest long‑term debt near $72M. For traders, that balance sheet means dilution or emergency funding is not the main risk right now.

More Breaking News

Valuation is where the story tightens. PATH trades around 3.2x sales and roughly 10x free cash flow, with a price‑to‑earnings ratio near 17. That’s cheaper than peak software bubbles but not “deep value” either. Combine that with revenue growth in the mid‑teens and PATH starts to look like a middle‑aged growth story, not the hyper‑growth rocket it once was.

Why Traders Are Watching PATH After The UBS Cut

The UBS price‑target cut on UiPath Inc. is small on paper — from $13 to $12 — but traders know these tweaks matter at key support levels. PATH has already been under quiet pressure. The daily chart shows PATH sliding from closes around $12.15–$12.20 earlier in the month down to $10.20 most recently. That’s roughly a 15% pullback without a major headline, and the UBS move adds a layer of caution.

Look at the recent range: PATH has bounced between about $10.50 and $12.50 over the past few weeks. Every time it pokes toward the mid‑$12s, sellers step in. The UBS cut basically tells the Street, “Don’t expect a big re‑rating higher right now.” For short‑term trading, that keeps a lid on sentiment. Neutral rating, lower target — this is a classic “show me” zone.

Intraday, PATH’s last session tells the same story. The stock opened near $10.77, spiked toward $10.95, then bled down to close at $10.20. Volume‑weighted action tracked a slow grind lower, with no aggressive bid stepping up in the afternoon. For momentum traders, that’s a red flag: PATH is not being defended strongly at prior support.

At the same time, PATH’s low debt, strong gross margin, and positive cash flow stop this from looking like a broken company. It’s more a sentiment reset. Active traders in the Tim Sykes community will treat this kind of tape as a potential “fade the pops” environment until PATH can reclaim and hold key levels like $11 and $12 on convincing volume.

Conclusion

UiPath Inc. sits at an interesting crossroads. PATH’s business is throwing off cash, margins are strong, and the balance sheet is clean. Yet the chart and the UBS call both say the same thing — expectations are being pulled down a notch. A Neutral rating plus a lower $12 target tells traders that big funds are not ready to chase PATH higher, at least not yet.

For short‑term trading, that usually means patience. Breakouts tend to fail when the Street is in wait‑and‑see mode. PATH will need a catalyst — stronger growth, a surprise beat, or a narrative shift — to pull price sustainably back above that mid‑teens valuation band UBS is signaling. Until then, every push toward prior resistance looks like a potential liquidity event for trapped longs.

The flip side is that PATH has real underlying strength, which can support sharp squeezes when sentiment finally turns. This is where discipline matters. As Tim Sykes loves to remind traders, “Cut losses quickly — that’s rule number one. If you ignore it, all the other rules won’t save you.” And as Tim Bohen, lead trainer with StocksToTrade says, “Time and experience have taught me that missed opportunities are part of the game. There’s always another setup around the corner.” With PATH pinned near the low end of its recent range and a fresh analyst trim in play, traders who respect risk, stalk clear levels, and react to price — not hope — will be the ones ready when the next big move finally shows up.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!